Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects
- PMID: 16797457
- DOI: 10.1016/j.crvi.2006.01.006
Differences in pharmacokinetic and electroencephalographic responses to caffeine in sleep-sensitive and non-sensitive subjects
Abstract
The present study investigated pharmacokinetic and electroencephalographic responses to caffeine (140 mg) in two groups of healthy volunteers reporting, or not, caffeine-related sleep disturbances. Significant differences in caffeine consumption and smoking habits were observed between the two groups. Plasma samples were taken from each subject before (T0) and after caffeine intake at 0.5, 1, 2, 4, 6 and 24 h. Three pharmacokinetic parameters: half-life (t1/2), maximum time (Tmax) and maximum plasma concentration (Cmax) were calculated from caffeine plasma concentration measurements determined by reversed phase HPLC analysis. Caffeine-sensitive subjects showed significantly greater half-life values when calculated on 24 h after the administration than tolerant subjects (p<0.05). Since the elimination kinetics were similar on the first 6 h after caffeine administration, the increased caffeine clearance observed overnight, when smoking was resumed in the control group, may indicate a short delay for the induction of hepatic cytochrome, reported here for the first time. Electrophysiological responses to caffeine, including vigilance and cortical activity, were assessed by ambulatory electroencephalographic (EEG) recorded during a period of 6 h before and after caffeine consumption. Following caffeine intake, the caffeine-intolerant subjects presented an increase in vigilance levels with faster peak alpha, beta frequency and lower delta and theta power when compared to tolerant subjects. Pharmacokinetic parameters and EEG data showed significant differences between sleep-sensitive and control subjects. These variations may be, in part, explained by cigarette smoking and the higher caffeine intake observed in the subjects of the control groups while caffeine sleep-sensitive subjects have a significantly lower caffeine intake, as already reported in previous studies on patients with sleep disturbances.
Similar articles
-
Challenging sleep in aging: the effects of 200 mg of caffeine during the evening in young and middle-aged moderate caffeine consumers.J Sleep Res. 2006 Jun;15(2):133-41. doi: 10.1111/j.1365-2869.2006.00518.x. J Sleep Res. 2006. PMID: 16704567 Clinical Trial.
-
Sleep duration and caffeine consumption in a French middle-aged working population.Sleep Med. 2005 May;6(3):247-51. doi: 10.1016/j.sleep.2004.10.005. Epub 2005 Jan 24. Sleep Med. 2005. PMID: 15854855
-
Smoking behaviour modulates pharmacokinetics of orally administered clopidogrel.J Clin Pharm Ther. 2008 Aug;33(4):439-49. doi: 10.1111/j.1365-2710.2008.00936.x. J Clin Pharm Ther. 2008. PMID: 18613862 Clinical Trial.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Psycho- and immunopharmacological factors relevant to selection of volunteers in clinical studies.Int J Clin Pharmacol Ther. 2001 Jul;39(7):300-10. doi: 10.5414/cpp39300. Int J Clin Pharmacol Ther. 2001. PMID: 11471774 Review.
Cited by 5 articles
-
The Influence of Caffeine Expectancies on Simulated Soccer Performance in Recreational Individuals.Nutrients. 2019 Sep 25;11(10):2289. doi: 10.3390/nu11102289. Nutrients. 2019. PMID: 31557945 Free PMC article. Clinical Trial.
-
The Influence of Caffeine Expectancies on Sport, Exercise, and Cognitive Performance.Nutrients. 2018 Oct 17;10(10):1528. doi: 10.3390/nu10101528. Nutrients. 2018. PMID: 30336606 Free PMC article. Review.
-
Caffeine effects on sleep taken 0, 3, or 6 hours before going to bed.J Clin Sleep Med. 2013 Nov 15;9(11):1195-200. doi: 10.5664/jcsm.3170. J Clin Sleep Med. 2013. PMID: 24235903 Free PMC article. Clinical Trial.
-
Coffee, caffeine, and risk of depression among women.Arch Intern Med. 2011 Sep 26;171(17):1571-8. doi: 10.1001/archinternmed.2011.393. Arch Intern Med. 2011. PMID: 21949167 Free PMC article.
-
Genetics of caffeine consumption and responses to caffeine.Psychopharmacology (Berl). 2010 Aug;211(3):245-57. doi: 10.1007/s00213-010-1900-1. Epub 2010 Jun 9. Psychopharmacology (Berl). 2010. PMID: 20532872 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical